Masimo Developed First-of-its-Kind Opioid Halo™ for Opioid Overdose Prevention

Masimo developed first-of-its-kind Opioid Halo™, which detects opioid-induced respiratory depression, the leading cause of opioid overdose death.

The Opioid Halo comprises of four components: 1) tetherless, adhesive fingertip sensor; 2) reusable Masimo SET® pulse oximeter and Bluetooth® chip; 3) Bluetooth-to-Wi-Fi Masimo Home Medical Hub; and 4) a smartphone application.

• The fingertip sensor helps in real-time monitoring of opioid-induced respiratory depression by using the Opioid Halo pattern recognition algorithm
• SET®, Signal Extraction Technology® works even during movement, when hands are cold, and on all skin pigmentations.
• Sensor and chip data are transmitted wirelessly to the Masimo Home Medical Hub
• Smartphone application helps the user’s to analyse physiological data for trends and patterns associated to the physiology of an opioid-induced respiratory depression event to quantify opioid risk.

The unique Opioid Halo engine, consisting of an advanced pattern recognition algorithm  helps to detect and quantify the risk of severe opioid-induced respiratory depression and advances the forefront of continuous monitoring.

Opioid Halo consists of an innovative distributed architecture, which helps to manage and send escalating alarms to family members, friends, and caregivers, to advise them regarding the help needed during opioid overdose – including triggering an automatic wellness call, that can lead to EMS being dispatched.

Opioid Halo is used at home, in hospitals or other medical facilities, by patients prescribed opioids after surgery or managing a chronic or prolonged condition, as well as individuals suffering from opioid use disorder.

Opioid Halo™ is the first and only FDA-authorized opioid overdose prevention and alert system.